Preliminary Program of 4^th Congress of SEUD

SIMULTANEOUS PRE-CONGRESS COURSES

Simulation and e-gynecology

Chair: Jean-Philippe Estrade (France)

• Augmented reality in gynecologic Laparoscopic, Nicolas Bourdel (France)
• Simulation in gynecology: training tools for endometriosis surgical treatment, Patrice Crochet (France)
• E-video as a training tool for surgeons, Patrice Crochet (France)
• Haptic feedback in robotic procedures: current work and perspectives, Claudio Pacchierotti (Italy)
• Contribution of a virtual hysteroscopic simulator in the learning of hysteroscopic myoma resection, Guillaume Legendre (France)
• A low cost laparoscopic simulation: interest of the three dimentional model. Ouzaher Hamza (Morocco)
• Virtual Reality for optimized learning: using high fidelity simulation to build skills for IUS insertion. Thomas Faustmann (France)
• Demonstration of the Pelvic Sim. Richard Vallot (France)
• Artificial Intelligence: What expect in healthcare ? Cédric Cavin (France)
• Question & Answer

NATIONAL SESSION: ALGERIA

Chair: Farid Benaibouche (Algeria)
(French-speaking session)

• Adenomyosis: How to do the diagnosis? Abdennour Youcef Khodja (Algeria)
• Can endometrectomy be a treatment for adenomyosis: An Algerian experience? Soumiya Kouar, Farid Benaibouche & Mourad Derguini (Algeria)
• Conservative surgical treatment of adenomyosis in subfertile women. Amel Dammene Debbih & Abdennour Youcef Khodja (Algeria)
• Which treatment for polyps? Mohammed Yassine Benmoumen & Fadl Allah Abou-Bekr (Algeria)
• Management of the endometrioma in infertile women: Algerian experience. Farouk Arbouz (Algeria)
• Place of embolization in the management of uterine myoma Experience of CHU Bab EL Oued, Fadhila Madaci (Algeria)
• Indication and methods of surgical treatment of submucosal myomas, Fadl Allah Abou-Bekr & Mohammed Yassine Benmoumen (Algeria)
• Discussion

NATIONAL SESSION: GREECE

Chair: George Pistofidis (Greece)

• How to Best Manage Uterine Problems that Occur as a Result of Fertility Postponement, George Pistofidis (Greece)
• Molecular Insights of Aging in Human Embryo Implantation, Antonis Makrigiannakis (Greece)
• Hysteroscopic Imaging of the Endometrial Cavity Through Aging, Minas Paschopoulos (Greece)
• Myomatous Occurrence in the Aging Uterus and Fertility, Nikos F Vlahos (Greece)
• Age Progression and Adenomyosis Related Symptoms, Protopappas Athanasios (Greece)

Imaging and uterine disorders

Chairs: Stefano Guerriero (Italy) & Anne-Elodie Millisher (France)

• The MUSA Protocol, Magrit Dueholm (Denmark)
• Adenomyosis and TVS, Thierry Van Den Bosch (Belgium)
• Adenomyosis and MR, Anne Elodie Millischer (France)
• Adenomyosis as tip of the iceberg of presence of pelvic deep endometriosis: the IDEA protocol, Stefano Guerriero (Italy)
• Fibroma and color Doppler: what’s new? Caterina Exacoustos (Italy)
• Endometrium and IETA protocol, Francesco Leone (Italy)
• Congenital uterine malformations: new insights, Artur Ludwin (Poland)

ART and clinical protocols for endometriosis

Chairs: Maria Elisabetta Coccia (Italy) & Rui A. Ferriani (Brazil)

• Does Endometriosis Affect IVF/ICSI Outcomes? Rui Alberto Ferriani (Brazil)
• Appropriate ovarian stimulation for endometriosis patients, Juan Garcia Velasco (Spain)
• Advanced endometriosis: Surgery or IVF? Pietro Santulli (France)
• Discussion

• Adenomyosis and infertility, Edgardo Somigliana (Italy)
• Fertility preservation in endometriosis patient as a real possibility to offer? Basil Tarlatzis (Greece)
• Integrated approach for infertile endometriosis patient: when? Maria Elisabetta Coccia (Italy)
• Discussion

LIVE SURGERY SESSION

from Negrar Hospital (Italy)

Chairs: Mauricio Abrão (Brazil)
Surgeons: Marcello Ceccaroni, Mario Malzon, Attilio Di Spiezio (Italy) & Alberto Mattei (Italy)

NATIONAL SESSION: RUSSIA

Chairs: Vera Balan (Russia), Alexander Popov (Russia)

• Experimental model of endometriosis: justification of target therapy, Maria Yarmolinskaya (Russia)
• Cardiovascular and oncological risks of endometriosis, Natalya Ermolova (Russia)
• Endometriosis-assisted infertility treatment according to RCOG guidelines, Alex Kseniya (UK) 
• Modern ways and trends in deep infiltrating endometriosis treatment. Exit from the comfort zone, Denis Tsepov (UK)
• Endometriosis in postmenopausal women, Vera Balan (Russia)

NATIONAL SESSION: JAPAN

Chair: Yutaka Osuga (Japan)

• Prostaglandin E2 – potential target for controlling endometriosis, Kaori Koga (Japan)
• Stem cells solve the enigma of endometriosis? Tetsuo Maruyama (Japan)
• Role of EMT in adenomyosis and its effect on reproductive outcome, Khaleque Khan (Japan)
• Role of ER beta in endometriosis, Fuminori Taniguchi (Japan)
• An etiology of endometriosis, from the point of autonomic nerve system, Osamu Yoshino (Japan)
• The role of AMH in the management of ovarian endometrioma, Michio Kitajima (Japan)

NATIONAL SESSION: CHINA

Surgical and Medical Treatment for Endometroisis

• Lateral pelvic wall dissection for patients with DIE. Jinhua Leng (China)
  
• Postoperative medical management for endometriosis. Yingfang Zhou (China)
• Evaluation on the long-term efficacy of conservative surgical treatment for adenomyosis. Xinmei Zhang (China)
• Surgical indications and skills for adolescent endometriosis. Keqin Hua (China)
• Surgical treatment for abdominal wall endometriosis. Yi Dai (China)
• Managing endometrisis related infertility-Optimizing Controlled Ovarian Hyperstimulation. Qing Xue (China)

NATIONAL SESSION: ITALY

The management of women suffering from Uterine Fibroids: the Italian experience

Chair: Stefano Uccella (Italy)

• Treating Women or treating fibroids?  Carlo Saccardi (Italy)      
• Medical treatment in women with UF eligible to surgery: preliminary results from MUST study, Giovanna Giarrè (Italy)
• Preserving fertility and enabling pregnancy in women with UF, Carlo Carravetta(Italy)
• Long term medical treatment of woman with UF. Morena Rocca (Italy)
  
• Wrap up and discussion

NATIONAL SESSION: EGYPT

Chair: Gamal Serour (Egypt)

• Subtle uterine infertility, Emad Darwish (Egypt)
• Emerging treatment endometriosis, Abo Bakr El-Nashar (Egypt)
• Conservative surgery in endometriosis, Hosam Thabet (Egypt)
• Endometrial receptivity: seed soil interaction or cross talk, Mohamed Salama Gad (Egypt)
• Challenges in adenomyosis management before ART, Afaf A. Ismail (Egypt)

NATIONAL SESSION: ARAB

Chair: Ghassan Lotfi (U.A.E)

• Uterine morcellation- perspective from the U.A.E. experience, Wael Sammur (U.A.E.)
• Facts about endometriosis in KSA, Sameer Sendy (KSA)   
• Prevalence of dysmenorrhoea among high school girls in Kuwait – A cross sectional study with multistage cluster sampling analysis, Salma Kayani (Kuwait)
• Endometriosis in teens: is it a reproductive stigma? Maryam Al Shukri (Oman)
• Laparoscopic surgery for endometriosis – The Bahraini experience, Salam Jebril (Bahrain)
• Ultrastructural study of ovocyte quality from patients with endometriosis undergoing In Vitro Fertilization (IVF), Afaf Ismail (Egypt)

NATIONAL SESSION: IRAN

Chairs: Parsa Nezhad (Iran), Taheri Panad (Iran)

• How to diagnose and manage colorectal endometriosis, Saeed Alborzi (Iran)
• Sclerotherapy in endometrioma, Abbas Aflatoonian (Iran)
• Adenomyosis and its effect on reproductive outcome, Saghar Salehpour (Iran)
• Key note points through ART in endometriosis-assisted infertility treatment, Mahnaz Ashrafi (Iran)
• Q & A

NATIONAL SESSION: CANADA

The Gynecologic Age of Enlightenment: From Tradition to Science

Chair: Sony Singh (Canada)

• In the beginning… Approach to common congenital uterine anomalies, Lisa Allen (Canada)
• Go with the Flow: Role of Algorithms in Fibroid Care, Liane Belland (Canada)
• The Endometriosis Renaissance – Fertility Unraveled, Sarah Maheux-Lacroix (Canada)
  
• Challenging the Status Quo, Improving Care in Gynecologic Surgery, Sony Singh (Canada)

NATIONAL SESSION: SPAIN

Chair: Dra. Alicia Hernández

• Patogénesis de la endometriosis. Papel del “stress oxidativo.” Iñaki Lete (Spain)
• Diagnóstico de la endometriosis en el siglo XXI. ¿Es necesaria la laparoscopia?” Cristina Ros (Spain)
  
• Tratamiento actual de la endometriosis. Una visión integrativa. Jesús Jiménez (Spain)
  
• Nuevas opciones en el tratamiento médico de la endometriosis. Maria-Angeles Martínez-Zamora (Spain)
• ¿Queda algún lugar para la cirugía en el tratamiento actual de la endometriosis? Juan Gilabert (Spain)
  

NATIONAL SESSION: LATIN AMERICA

Chair: Juan Salgado (USA)

• Double stappler technique for bowel endometriosis: how and why? Thiers Raymundo (Brazil) 
• Conservative surgical treatment of adenomyosis. Francisco Carmona (Spain)
• Transvaginal sonography with bowel prep, Can predict complexity of  surgery for DIE? Juan Salgado (USA)
• Surgical and practical anatomy to endometriosis: tips and tricks. Luiz Flavio Fernandes  (Brazil)

NATIONAL SESSION: APAGE

Chairman: Chyi-Long Lee (Taiwan)

• Fertility Outcome of Adenomyomectomy. Chih-Feng Yen (Taiwan)
• Preventing urinary complications of MIS surgeries. Chong Kiat Khoo (Singapore)
• Robotic Reconstructive Surgery in Urinary Tract Endometriosis. Chyi-Long Lee (Taiwan)

EU MOMENDO SESSION

Chairs: Martin Götte (Germany) Ludwig Kiesel (Germany)

• Learning from cancer to treat endometriosis, Andrew Horne (UK)
• Use of the Endometriosis Fertility Index in the management of endometriosis-associated infertility, Carla Tomassetti (Belgium)
• Role of microRNAs in endometriosis, Martin Götte (Germany)
• Current Strategies for the treatment of endometriosis compromising the bowel, Mauricio Abrão (Brazil)

ABBVIE SYMPOSIUM
The impact of endometriosis on a patient’s life course: can early intervention alter the trajectory?

Room Verde

• Introduction, Sony Singh (Canada)
• Can endometriosis alter the trajectory of a patient’s life? Hugh Taylor (USA)
• Endometriosis management: can we advance the treatment paradigm? Charles Chapron (France)
• Unravelling the cumulative life impact of endometriosis: facilitated discussion, Sony Singh (Canada)
• Close: a call to action, Sony Singh (Canada)

BAYER SYMPOSIUM
Endometriosis evidence in context: Understanding long-term treatment in clinical practice

• Welcome and introduction, Michael Mueller (Switzerland)
• The relevance of real-world evidence in endometriosis treatment, Oskari Heikinheimo (Finland)
• VIPOS: What can we learn about patients with endometriosis today?, Sara Imboden (Switzerland)
• Looking at long-term medical treatment: Evidence and experience with dienogest 2 mg, Michele Vignali (Italy)
• Discussion with audience participation and closing

Speakers: Charles Chapron (France) & Felice petraglia (Italy)

GENETIC / EPIGENETIC AND ENVIRONMENTAL FACTORS FOR ENDOMETRIOSIS

Chairs: Pierluigi Benedetti Panici (Italy) & Krina Zondervan (United Kingdom)

• The state of the art, Peters Rogers (Australia)
• The basic science, Daniel Vaiman (France)
• The future directions, Hugh Taylor (USA)
• Role of microRNA’s in Endometriosis, Asgi Fazleabas (USA)

Keynote Lecture

Chair: Robert Taylor (USA)

• Molecular mechanisms of endometriosis onset and progression, Bert W. O’Malley (USA)

ENDOCRINOLOGY / HORMONAL FACTORS FOR ENDOMETRIOSIS

Chairs: Yoke Fai Fong (Singapore) & Paolo Vercellini (Italy)

• The state of the art, Linda Giudice (USA)
• The basic science, Serdar Bulun (USA)
• The clinical implications, Felice Petraglia (Italy)
• The future directions, Robert Casper (Canada)

IMMUNOLOGICAL FACTORS IN ENDOMETRIOSIS

Chairs: Margit Dueholm (Denmark) & Massimo Candiani (Italy)

• The clinical implications, Paola Viganò (Italy)
• The basic science, Robert Taylor (USA)
• The clinical implications, Chris Becker (United Kingdom)
• The future directions, Frédéric Batteux (France)

GEDEON RICHTER SYMPOSIUM:
UTERINE FIBROIDS, EXPERIENCE AND PERSPECTIVES

• Uterine Fibroids: A rational for medical treatment, Roberto Marci (Italy)
• Markers of uterine fibroid response to UPA, Marie Madeleine Dolmans (Belgium)
• Ten years of cumulative experience with UPA, Jacques Donnez (Belgium)

Keynote Lecture

Chair: Charles Chapron (France)

• How to treat the complex patients: endometrioisis, adenomyosis and uterine fibroids, Michael Muller (Switzerland)

LIFE STYLE AND STRESS FACTORS FOR ENDOMETRIOSIS AND UTERINE DISORDERS

Chairs: Sarah Berga (USA) & Sony Singh (Canada)

• Pain, endometriosis and quality of life, Sylvya Mechsner (Germany)
• Stress and endometriosis, Fernando Reis (Brazil)
• Adenomyosis and quality of life, Francisco Carmona (Spain)
• Coexistence of endometriosis and uterine disorders in infertile patients, Ludwig Kiesel (Germany)

IPSEN SYMPOSIUM:
From endometriosis to pregnancy, what is the ‘best’ strategy?

Chair: Charles Chapron (France)

• Endometrioma and infertility, should we rethink our approach? Charles Chapron (France)
• Managing infertility when adenomyosis and endometriosis co-exist, Jinhua Leng (China)
• Achieving IVF success in women with endometriosis, Juan Garcia Velasco (Spain)

MEDTRONIC SYMPOSIUM :
Understanding the patient pathway for uterine cancer: hysteroscopy to hysterectomy

Chair: Helder Ferriera (Portugal)

LUMENIS SYMPOSIUM
The positive impact of Lumenis CO2 Laser on Fertility Preservation

Chair: Francisco Carmona (Spain)
Panel of experts: Mariona Rius (Spain) & Jessica Ottolina (Italy)

The impact on ovarian reserve of ovarian cystectomy versus laser vaporization in the treatment of ovarian endometrioma, Jessica Ottolina (Italy)

WORKSHOP
Fibroids and new hormonal treatments

Chairs: Philippe Y. Laberge (Canada) & Tommaso Simoncini (Italy)

• Beyond the horizon: novel and developing medical strategies for the treatment of fibroids, Sony Singh (Canada)
• New algorithm in the management of uterine fibroids, Jacques Donnez (Belgium)
• Emerging medical treatments for uterine fibroids, Kristof Chwalisz (USA)

Free communications

Free communications 1Room Verde

Chairs: Alexander Popov (Russia) & Silvia Vannuccini (Italy)

• MRNAs and miRNAs expression profiles in adenomyosis and their potential uses as diagnostic biomarkers, Delphine Haouzi (France)
• Influence of adenomyosis on pregnancy and perinatal outcomes in patients with endometriosis, Ritsuo Honda (Japan)
• Examination of  abnormal myometrial peristalsis and contraction  due to morphological difference of adenomyosis, Ikuko Ota (Japan)
• Influence of adenomyosis on clinical pregnancy in oocyte donation program, Sara Peralta (Spain)
• FAK regulate EMT process in adenomyosis through a PI3K/AKT pathway, Wang Sha (China)
• Co-existence and pre-operative detection of endometriosis and adenomyosis in women undergoing surgery for deep infiltrating endometriosis, Linda Tebache (Belgium)

Free communications 2Room Onice

Chairs: Bruno Borghese (France) & Paola Piomboni (Italy)

• Aberrant expression of cancer associated markers identified within endometrioma in a subset of women with endometriosis, Karin Louise Andersson (Italy)
• Kir genes and their hla-ligands as markers for endometriosis risk, Mauricio Abrão (Brazil)
• Role of microRNAS, angiogenic and fibrinolytic factors and cytokines in the peritoneal fluid of patients with endometriosis and their relation to sterility, Marí-Alexandre Josep (Spain)
• DNA Methylation of Progesterone Receptor B (PR-B) Gene in Human Eutopic Endometrium, Ectopic Peritoneal and Ovarian Endometriosis, Gustar Darmawi (Indonesia)
• Bioinformatic analyses of transcriptomic data in endometriosis for identifying regulating miRNAS, Bruno Borghese (France)
• Notch1 expression in superficial and deep endometriotic lesions: a pilot study, Fernando M. Reis (Brazil)

Free communications 3Room 4

Chairs: Saeed Alborzi (Iran) & Stefano Angioni (Italy)

• GnRH Receptor Antagonist KLH-2109 dose-dependent E2 suppression in Japanese and Caucasian women, Oliver Pohl (Switzerland)
• Reproductive outcomes in infertile patients with deep endometriosis treated by laparoscopic surgery, Marco Orlando (Italy)
• Dienogest treatment of patients with ovarian endometriomas, Maria Elena Malune (Italy)
• The impact on ovarian reserve of ovarian cystectomy versus laser vaporization in the treatment of ovarian endometrioma: a randomized clinical trial, Jessica Ottolina (Italy)
• Recurrences of pain and lesions after a first surgery for endometriosis in the long term, Nicolas Bourdel (France)
• A prospective clinical trial; comparing IVF outcomes anA prospective clinical trial; comparing IVF outcomes and recurrence of endometrioma in patients with sclerotherapy versus laparoscopic cystectomy d recurrence of endometrioma in patients with sclerotherapy versus laparoscopic cystectomy, Saeed Alborzi (Iran)

Free communications 4Room 9

Chairs: Jean Pierre Gotteland (CH) & Pietro Litta (Italy)

• Leiomyoma: expression of inflammatory genes and metalloproteinases, Claudia Tosti (Italy)
• Influence of Ethnicity on Clinical Presentation and Quality of Life in Women With Uterine Fibroids, Olga Bougie (Canada)
• Assessment of the safe and efficacious dose of the selective progesterone receptor modulator vilaprisan (VPR) for the treatment of patients with uterine fibroids by exposure–response modeling and simulation, Bart Ploeger (Germany)
• Radiofrequency myolysis: tailored management by ultrasound, hysteroscopic and laparoscopic single or combined procedures, Alessandro Fasciani (Italy)
• Management of uterine artery pseudoaneurysm after laparoscopic myomectomy, Ryo Nimura (Japan)
• Follow-up of myomectomies by outpatient hysteroscopy, Puerta Sanabria Jose María (Spain)

Free communications 5Room 101

Chairs: Maria Grazia Porpora (Italy) & Afaf Ismail (Egypt)

• Intrauterine fundal anesthesia during endometrial ablation in the outpatient clinic: a randomized, double-blind,  non-inferiority trial, Imke Reinders (Netherlands)
• Long term Follow Up of a Randomised Controlled Trial Comparing Novasure® and Thermablate® Endometrial Ablation for Heavy Menstrual Bleeding, Marlies Bongers (Netherlands)
• Development and validation of a screening questionnaire to detect heavy menstrual bleeding in gynaecology, Joaquim Calaf Alsina (Spain)
• DCE-MRI of uterine microvasculature in women with heavy menstrual bleeding (HMB) treated with a selective progesterone receptor modulator (SPRM), Hui Wei Leow (United Kingdom)
• Long term reproductive outcomes after Hysteroscopic Outpatient Metroplasty to Expand Dysmorphic Uteri (HOME- DU technique) in infertile women, Vera Donadono (Italy)
• Effect of tibolone on the survival of early stage cervical adenocarcinoma patients, Lee Seungho (Korea)
• HPV prevalence and viral load in women with rASRM stage 1-2 endometriosis, Dmitry Buryak (Belarus)

WORKSHOP
Non hormonal treatments for endometriosis

Chairs: Tasuku Harada (Japan) & Oskari Heikinheimo (Finland)

• The impact of diet and supplements on endometriosis, Yutaka Osuga (Japan)
• New treatments for ovarian endometrioma, Ivo Brosens (Belgium)
• Innovative ways to relieve women from the burden of endometriosis, Thomas Zollner (Germany)

Free communications

Free communications 6Room 4

Chairs: Yi Dai (China) & Antonio Maiorana (Italy)

• Influence of bowel preparation in the performance of transvaginal ultrasonography in the diagnosis of rectosigmoid endometriosis, Simone Ferrero (Italy)
• Sonographic prevalence of uterine disorders in women with endometriosis: a retrospective study, Tommaso Capezzuoli (Italy)
• Circulating Cf-DNA quantification according to the location of the endometriotic lesions, Delphine Haouzi (France)
• Predictive factor of bowel endometriosis: a continuous cohort of 1395 histologically proven endometriosis patients, Louis Marcellin (France)
• Does body mass index affect the accuracy of transvaginal ultrasound with bowel-preparation for deeply infiltrating endometriosis? Scott Young (USA)
• The overall and cause-specific mortality of mid-life women with surgically verified endometriosis, Oskari Heikinheimo (Finland)

Free communications 7Room Onice

Chairs: Pere Barri (Spain) & Vito Cela (Italy)

• Current management of diaphramatic and thoracic endometriosis: a French multicentric retrospective study, Alexia Wetzel (France)
• Elagolix Reduced Rescue Opioid Use in Two Phase 3 Randomized, Placebo-controlled Trials in Women with Endometriosis-associated Pain, Hugh S. Taylor (USA)
• Endocannabinoid – Endometriosis – Artificial intelligence: Let s get high ! Jérôme Bouaziz (Israel)
• Deep infiltrating endometriosis: a previous history of surgery for endometriosis may negatively affect assisted reproductive technology outcomes, Chloé Maignien (France)
• Pregnancy outcome in patients with previous endometriosis eradication surgery, Giovanni Morganelli (Italy)
• Oral administration of the AKR1C3 inhibitor BAY1128688 over 28 days does not interfere with ovarian function in healthy women, Jan Hilpert (Germany)
• Diverting stoma-related complications following colorectal  endometriosis surgery: a 163 patient cohort, Horace Roman (France)

Free communications 8Room 9

Chairs: Abayomi Ajayi (Senegal) & Attilio di Spiezio (Italy)

• Incomplete removal of Essure, Sebastiaan Veersema (Netherlands)
• Do endometriomas affect ovarian response to controlled ovarian stimulation? : a comparative study for age and anti-Müllerian hormone, Iñaki González-Foruria (Spain)
• Different antiadhesion barrier application during hysteroscopic adhesiolysis, Anton Fedorov (Russia)
• Prevalence of unsuspected uterine alterations in women undergoing routine hysteroscopy before in vitro fertilization: a single center, retrospective cohort study, Fernando M. Reis (Brazil)
• Uterine-tubal factors associated with Endometriosis diagnosed at Laparoscopy in Nigeria, Abayomi Ajayi (Nigeria)
• Oxidative stress in follicular fluid of infertile women undergoing In Vitro Fertilization: what happens in endometriosis patients? Maria Elisabetta Coccia (Italy)

Free communications 9Room 101

Chairs: Rosanne M. Kho (Usa) & Massimiliano Fambrini (Italy)

• Impact of ovarian endometrioma and deep infiltrating endometriosis on adverse maternal and perinatal pregnancy outcomes, Fabio Barra (Italy)
• IL-33/ST2 axis affects the polarization and efferocytosis of decidual macrophages in early pregnancy, Yanran Sheng (China)
• High postoperative fertility rate following surgical management of colorectal endometriosis: 4 year follow up of patients enrolled in ENDORE randomized trial, Horace Roman (France)
• Fertility-sparing combined hysteroscopic and medical treatment of atypical endometrial hyperplasia and early endometrial cancer in young women, Pierluigi Giampaolino (Italy)
• Prevalence of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary, Jia Shuang-zheng (China)
• Laparoscopic treatment of genital prolapse by lateral suspension in patients with deep endometriosis, Giacomo Serboli (France)

Videos session 1

Room Verde

Chairs: Kathy Huang (Usa) & Marcello Ceccaroni (Italy)

• Conservative management using the triple approach and the Rouen technique in large deep rectovaginal endometriosis involving low rectum and sacral roots, Horace Roman (France)
• Surgical technique for right-sided diaphragmatic endometriosis (DE) – What we have learned from 36 cases, Duarte Ribeiro (Brazil)
• Stepwise Approach to Excision of Superficial Endometriosis, Michael Suen (Canada)
• Can Argon Plasma Coagulation treatment of Endometriomas protect ovarian reserve? I-Ferne Tan (Singapore)
• Approach to the Obliterated Cul-de-sac, Michael Suen (Canada)
• Laproscopic surgical technique for complete excision of focal adenomyosis by using Transient occlusion of uterine arteries (TOUA) technique, Jae Young Kwack (Korea)

WORKSHOP
Abnormal uterine bleeding and minimally invasive surgery

Chairs: Masaaki Andou (Japan) & Ludovico Muzii (Italy)

• Surgical treatment of fibroma for subfertility, Andrew Horne (United Kingdom)
• AUB and hysteroscopy, Philippe Y. Laberge (Canada)
• Fibroids and resettoscopy, Stefano Luisi (Italy)

AN UPDATE ON THE DIAGNOSIS OF ADENOMYOSIS

Chairs: Jin Hua Leng (China) & Carmine Nappi (Italy)

• The basic science, Sun-Wei Guo (China)
• The state of the art, Mauricio Abrao (Brazil)
• The clinical implications, Charles Chapron (France)
• The future directions, Thierry Van den Bosh (Belgium)

Keynote Lecture

Chair: Fulvio Zullo (Italy)

• Abnormal uterine bleeding in fertile age: minimally invasive surgical solution, Grigoris F. Grimbizis (Greece)

PHENOTYPE OF UTERINE FIBROIDS AND CLINICAL SYMPTOMS

Chairs: Edgardo Somigliana (Italy) & Gamal Serour (Egypt)

• State of the art: optimizing symptom management, Hilary Critchley (United Kingdom)
• The basic science, Pascquapina Ciarmela (Italy)
• The clinical implications, Caterina Exacoustos (Italy)
• The future directions, William H. Catherino (USA)

SEUD meets the patients